Yuming Wang Selected Research

Inflammasomes

12/2023	DHA and EPA Alleviate Epileptic Depression in PTZ-Treated Young Mice Model by Inhibiting Neuroinflammation through Regulating Microglial M2 Polarization and Improving Mitochondrial Metabolism.
12/2019	Eicosapentaenoic Acid-Enriched Phosphatidylcholine Mitigated Aβ1-42-Induced Neurotoxicity via Autophagy-Inflammasome Pathway.
5/2018	A comparative study of EPA-enriched ethanolamine plasmalogen and EPA-enriched phosphatidylethanolamine on Aβ42 induced cognitive deficiency in a rat model of Alzheimer's disease.
5/2018	Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuming Wang Research Topics

Disease

41	Neoplasms (Cancer) 02/2024 - 06/2006
28	Chronic Hepatitis B 01/2022 - 08/2004
26	Inflammation (Inflammations) 03/2024 - 10/2014
20	Insulin Resistance 01/2023 - 10/2012
18	Infections 03/2022 - 08/2004
12	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2015
12	Obesity 01/2023 - 10/2012
11	Fibrosis (Cirrhosis) 01/2022 - 10/2011
9	Non-alcoholic Fatty Liver Disease 08/2020 - 01/2016
8	Cholangiocarcinoma 04/2024 - 04/2018
8	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 08/2013
8	Hypoxia (Hypoxemia) 12/2023 - 08/2017
8	Body Weight (Weight, Body) 09/2022 - 06/2002
8	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2016
7	Colitis 02/2024 - 01/2018
7	Hepatitis B 01/2022 - 01/2012
6	Carcinogenesis 11/2023 - 01/2019
6	Glucose Intolerance 01/2022 - 10/2012
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 10/2011
5	Osteosarcoma (Osteogenic Sarcoma) 07/2023 - 05/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 01/2018
5	Liver Diseases (Liver Disease) 07/2014 - 02/2008
4	Dysbiosis 03/2024 - 01/2020
4	Neuroinflammatory Diseases 12/2023 - 05/2018
4	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2015
4	Rheumatoid Arthritis 03/2023 - 12/2015
4	Cockayne Syndrome (Syndrome, Cockayne) 01/2023 - 01/2016
4	Coronary Disease (Coronary Heart Disease) 09/2022 - 01/2019
4	Metabolic Diseases (Metabolic Disease) 01/2022 - 04/2017
4	Fatty Liver 01/2019 - 05/2012
3	Neoplasm Metastasis (Metastasis) 02/2024 - 09/2016
3	Sepsis (Septicemia) 11/2023 - 01/2020
3	Necrosis 11/2023 - 01/2018
3	Pain (Aches) 09/2022 - 01/2019
3	Osteoporosis 04/2022 - 11/2020
3	Esophageal Squamous Cell Carcinoma 01/2022 - 12/2019
3	Hyperlipidemias (Hyperlipidemia) 09/2021 - 01/2016
3	Heart Failure 03/2021 - 05/2019
3	Disease Progression 01/2021 - 10/2011
3	Keloid 08/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2008
18	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 10/2012
15	Biomarkers (Surrogate Marker)IBA 11/2023 - 08/2013
14	Insulin (Novolin)FDA Link 01/2022 - 10/2012
13	Hepatitis B e AntigensIBA 10/2020 - 12/2007
11	Therapeutic UsesIBA 09/2022 - 02/2002
10	EnzymesIBA 01/2024 - 10/2017
10	Phospholipids (Phosphatides)FDA LinkGeneric 07/2023 - 07/2013
10	LipidsIBA 09/2021 - 05/2012
9	Lamivudine (Epivir)FDA Link 01/2014 - 01/2007
8	Eicosapentaenoic AcidIBA 01/2023 - 07/2013
8	Docosahexaenoic AcidsIBA 01/2023 - 01/2016
8	CytokinesIBA 10/2021 - 07/2013
7	SaponinsIBA 04/2022 - 10/2012
6	astaxanthine (astaxanthin)IBA 01/2024 - 05/2018
6	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 07/2013
6	Blood Glucose (Blood Sugar)IBA 01/2022 - 10/2012
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2020 - 04/2009
6	Telbivudine FDA Link 08/2015 - 12/2007
5	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 01/2023
5	Phosphatidylcholines (Phosphatidylcholine)IBA 09/2020 - 01/2016
5	Orotic AcidIBA 07/2020 - 05/2012
5	Antiviral Agents (Antivirals)IBA 06/2020 - 02/2008
4	Tryptophan (L-Tryptophan)FDA Link 03/2024 - 01/2023
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2019
4	Peptides (Polypeptides)IBA 01/2024 - 01/2013
4	InflammasomesIBA 12/2023 - 05/2018
4	RNA (Ribonucleic Acid)IBA 10/2023 - 08/2017
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2023 - 01/2022
4	Triglycerides (Triacylglycerol)IBA 01/2023 - 04/2018
4	chiglitazarIBA 01/2023 - 01/2022
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 04/2014
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 04/2018
4	phosphatidylethanolamineIBA 09/2020 - 05/2018
4	Sucrose (Saccharose)IBA 09/2020 - 07/2014
4	Cisplatin (Platino)FDA LinkGeneric 09/2020 - 06/2016
4	Messenger RNA (mRNA)IBA 07/2020 - 01/2016
4	microcinIBA 02/2020 - 01/2018
4	Histone Deacetylases (Histone Deacetylase)IBA 12/2019 - 11/2017
4	Amino Acids FDA Link 11/2019 - 09/2002
4	entecavir FDA Link 03/2014 - 01/2007
3	Peptide Hydrolases (Proteases)FDA Link 01/2024 - 01/2020
3	AntioxidantsIBA 12/2023 - 01/2019
3	MicroRNAs (MicroRNA)IBA 11/2023 - 11/2016
3	Volatile Fatty AcidsIBA 03/2023 - 09/2017
3	Butyrates (Butyrate)IBA 03/2023 - 01/2018
3	Liposomes (Liposome)IBA 02/2023 - 02/2018
3	NucleotidesIBA 01/2023 - 10/2019
3	Mitogen-Activated Protein KinasesIBA 04/2022 - 01/2018
3	ErbB Receptors (EGF Receptor)IBA 04/2022 - 09/2019
3	Antimicrobial PeptidesIBA 03/2022 - 01/2018
3	SphingolipidsIBA 01/2022 - 03/2017
3	SugarsIBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
3	Dextran SulfateIBA 12/2021 - 09/2018
3	phosphatidal ethanolaminesIBA 01/2021 - 05/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2018
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 04/2018

Therapy/Procedure

32	Therapeutics 12/2023 - 06/2006
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021 - 01/2017